GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Numinus Wellness Inc (OTCPK:NMNWF) » Definitions » Research & Development

Numinus Wellness (Numinus Wellness) Research & Development : $0.36 Mil (TTM As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Numinus Wellness Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Numinus Wellness's Research & Development for the three months ended in Feb. 2024 was $0.01 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 was $0.36 Mil.


Numinus Wellness Research & Development Historical Data

The historical data trend for Numinus Wellness's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numinus Wellness Research & Development Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23
Research & Development
0.11 0.14 1.11 1.46 0.87

Numinus Wellness Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.20 0.15 0.01 0.01

Numinus Wellness Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Numinus Wellness  (OTCPK:NMNWF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Numinus Wellness Research & Development Related Terms

Thank you for viewing the detailed overview of Numinus Wellness's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Numinus Wellness (Numinus Wellness) Business Description

Traded in Other Exchanges
Address
801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.